These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39363032)

  • 1. Characteristics of autosomal dominant WFS1-associated optic neuropathy and its comparability to OPA1-associated autosomal dominant optic atrophy.
    de Muijnck C; Haer-Wigman L; van Everdingen JAM; Lushchyk T; Heutinck PAT; van Dooren MF; Kievit AJA; Verhoeven VJM; Simon MEH; Wasmann RA; Notting IC; De Baere E; Walraedt S; De Zaeytijd J; Van den Broeck F; Leroy BP; Boon CJF; van Genderen MM
    Sci Rep; 2024 Oct; 14(1):22956. PubMed ID: 39363032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment.
    Rendtorff ND; Lodahl M; Boulahbel H; Johansen IR; Pandya A; Welch KO; Norris VW; Arnos KS; Bitner-Glindzicz M; Emery SB; Mets MB; Fagerheim T; Eriksson K; Hansen L; Bruhn H; Möller C; Lindholm S; Ensgaard S; Lesperance MM; Tranebjaerg L
    Am J Med Genet A; 2011 Jun; 155A(6):1298-313. PubMed ID: 21538838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant optic atrophy with
    Maeda-Katahira A; Nakamura N; Hayashi T; Katagiri S; Shimizu S; Ohde H; Matsunaga T; Kaga K; Nakano T; Kameya S; Matsuura T; Fujinami K; Iwata T; Tsunoda K
    Mol Vis; 2019; 25():559-573. PubMed ID: 31673222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.
    Ham M; Han J; Osann K; Smith M; Kimonis V
    Mitochondrion; 2019 May; 46():262-269. PubMed ID: 30165240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations.
    Yu-Wai-Man P; Bailie M; Atawan A; Chinnery PF; Griffiths PG
    Eye (Lond); 2011 May; 25(5):596-602. PubMed ID: 21378995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene.
    Eiberg H; Hansen L; Kjer B; Hansen T; Pedersen O; Bille M; Rosenberg T; Tranebjaerg L
    J Med Genet; 2006 May; 43(5):435-40. PubMed ID: 16648378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WFS1 in Optic Neuropathies: Mutation Findings in Nonsyndromic Optic Atrophy and Assessment of Clinical Severity.
    Grenier J; Meunier I; Daien V; Baudoin C; Halloy F; Bocquet B; Blanchet C; Delettre C; Esmenjaud E; Roubertie A; Lenaers G; Hamel CP
    Ophthalmology; 2016 Sep; 123(9):1989-98. PubMed ID: 27395765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies.
    Yu-Wai-Man P; Shankar SP; Biousse V; Miller NR; Bean LJ; Coffee B; Hegde M; Newman NJ
    Ophthalmology; 2011 Mar; 118(3):558-63. PubMed ID: 21036400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early macular retinal ganglion cell loss in dominant optic atrophy: genotype-phenotype correlation.
    Barboni P; Savini G; Cascavilla ML; Caporali L; Milesi J; Borrelli E; La Morgia C; Valentino ML; Triolo G; Lembo A; Carta A; De Negri A; Sadun F; Rizzo G; Parisi V; Pierro L; Bianchi Marzoli S; Zeviani M; Sadun AA; Bandello F; Carelli V
    Am J Ophthalmol; 2014 Sep; 158(3):628-36.e3. PubMed ID: 24907432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Spectrum and Characteristics of Hereditary Optic Neuropathy in Taiwan.
    Lin CW; Huang CW; Luo AC; Chou YT; Huang YS; Chen PL; Chen TC
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy.
    Chen Y; Jia X; Wang P; Xiao X; Li S; Guo X; Zhang Q
    Mol Vis; 2013; 19():292-302. PubMed ID: 23401657
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Nitta Y; Osaka J; Maki R; Hakeda-Suzuki S; Suzuki E; Ueki S; Suzuki T; Sugie A
    Elife; 2024 Aug; 12():. PubMed ID: 39177028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WFS1 protein expression correlates with clinical progression of optic atrophy in patients with Wolfram syndrome.
    Hu K; Zatyka M; Astuti D; Beer N; Dias RP; Kulkarni A; Ainsworth J; Wright B; Majander A; Yu-Wai-Man P; Williams D; Barrett T
    J Med Genet; 2022 Jan; 59(1):65-74. PubMed ID: 34006618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.
    Yu-Wai-Man P; Griffiths PG; Burke A; Sellar PW; Clarke MP; Gnanaraj L; Ah-Kine D; Hudson G; Czermin B; Taylor RW; Horvath R; Chinnery PF
    Ophthalmology; 2010 Aug; 117(8):1538-46, 1546.e1. PubMed ID: 20417570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic Optic Atrophy 1 (
    Othman BA; Ong JE; Dumitrescu AV
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segregation of two variants suggests the presence of autosomal dominant and recessive forms of
    Lusk L; Black E; Vengoechea J
    J Med Genet; 2020 Feb; 57(2):121-123. PubMed ID: 31363008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size.
    Barboni P; Carbonelli M; Savini G; Foscarini B; Parisi V; Valentino ML; Carta A; De Negri A; Sadun F; Zeviani M; Sadun AA; Schimpf S; Wissinger B; Carelli V
    Ophthalmology; 2010 Aug; 117(8):1547-53. PubMed ID: 20417568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distributed abnormalities of brain white matter architecture in patients with dominant optic atrophy and OPA1 mutations.
    Rocca MA; Bianchi-Marzoli S; Messina R; Cascavilla ML; Zeviani M; Lamperti C; Milesi J; Carta A; Cammarata G; Leocani L; Lamantea E; Bandello F; Comi G; Falini A; Filippi M
    J Neurol; 2015 May; 262(5):1216-27. PubMed ID: 25794858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier.
    Bonifert T; Karle KN; Tonagel F; Batra M; Wilhelm C; Theurer Y; Schoenfeld C; Kluba T; Kamenisch Y; Carelli V; Wolf J; Gonzalez MA; Speziani F; Schüle R; Züchner S; Schöls L; Wissinger B; Synofzik M
    Brain; 2014 Aug; 137(Pt 8):2164-77. PubMed ID: 24970096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant optic atrophy.
    Lenaers G; Hamel C; Delettre C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P; Milea D
    Orphanet J Rare Dis; 2012 Jul; 7():46. PubMed ID: 22776096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.